美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Daiichi Sankyo Co., Ltd.

24.44

+0.20000.83%

盘后：24.06-0.3775-1.54%17:43 EDT

成交量：46.26万

成交额：1,145.76万

市值：468.42亿

市盈率：32.91

高：25.43

开：25.07

低：24.43

收：24.24

数据加载中...

总览公司新闻公告

第一三共(DSNKY.US)ADC癌症新药在中国获批临床

美国OTC市场第一三共盘中异动股价大涨6.75%

美国OTC市场第一三共盘中异动早盘股价大涨5.08%

美国OTC市场第一三共盘中异动早盘快速拉升6.70%报24.53美元

美国OTC市场第一三共盘中异动早盘股价大跌6.93%

第一三共(DSNKY.US)与阿斯利康(AZN.US)潜在重磅抗癌ADC获推荐在欧盟上市

修正：第一三共公司第三季度每股收益同比增长至$0.22，销售额从$3.05B增长至$3.18B

第一三共公司第四季度每股收益0.22美元，同比增长0.10美元，销售额31.8亿美元，同比增长30.5亿美元

美国OTC市场第一三共盘中异动快速下跌5.75%

美国OTC市场第一三共盘中异动早盘股价大涨9.26%

第一三共(DSNKY.US)口服抗肿瘤新药在中国申报上市

阿斯利康(AZN.US)和第一三共(DSNKY.US)的抗体偶联药物datopotamab deruxtecan获FDA优先审评资格

第一三共(DSNKY.US)申报的DS-3939a临床试验申请已获得受理为该产品首次在中国申报临床

美国OTC市场第一三共盘中异动早盘股价大涨5.46%报34.02美元

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/DSNKY/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"DSNKY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DSNKY\",,,,,undefined,":{"symbol":"DSNKY","market":"US","secType":"STK","nameCN":"Daiichi Sankyo Co., Ltd.","latestPrice":24.44,"timestamp":1743710400000,"preClose":24.24,"halted":0,"volume":462633,"hourTrading":{"tag":"盘后","latestPrice":24.0625,"preClose":24.44,"latestTime":"17:43 EDT","volume":16,"amount":385,"timestamp":1743716588598},"delay":15,"floatShares":1876450459,"shares":1916602000,"eps":0.742527,"marketStatus":"未开盘","change":0.2,"latestTime":"04-03 16:00:00 EDT 延时","open":25.07,"high":25.43,"low":24.43,"amount":11457573.014499977,"amplitude":0.041254,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":0.742527,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1743753600000},"marketStatusCode":0,"adr":0,"adrRate":1,"exchange":"PINK LIMITED","adjPreClose":24.24,"volumeRatio":1.545038},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DSNKY\",,,,,undefined,":{"symbol":"DSNKY","floatShares":1876450459,"roa":"4.94%","roe":"15.29%","lyrEps":0.692127,"volumeRatio":1.545038,"shares":1916602000,"dividePrice":0.41184,"high":25.43,"amplitude":0.041254,"preClose":24.24,"low":24.43,"week52Low":22.47,"pbRate":"4.20","psRate":"3.80","week52High":42.48,"institutionHeld":0,"latestPrice":24.44,"eps":0.742527,"divideRate":0.016851,"volume":462633,"delay":15,"ttmEps":0.742527,"open":25.07,"prevYearClose":27.29,"prevWeekClose":24.45,"prevMonthClose":23.88,"prevQuarterClose":23.88,"fiveDayClose":25.02,"twentyDayClose":23.45,"sixtyDayClose":27.37,"earningDate":1745424000000,"earningTime":"盘后"},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"DSNKY\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2517815279","title":"第一三共(DSNKY.US)ADC癌症新药在中国获批临床","url":"https://stock-news.laohu8.com/highlight/detail?id=2517815279","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517815279?lang=zh_cn&edition=fundamental","pubTime":"2025-03-06 21:20","pubTimestamp":1741267210,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，3月6日，中国国家药监局药品审评中心官网公示，第一三共申报的1类新药DS-3939a获批临床，拟开发治疗实体瘤。公开资料显示，DS-3939a是一种靶向肿瘤相关MUC1的抗体偶联药物，正在全球范围内处于1/2期临床研究阶段。根据CDE官网查询，本次为该产品首次在中国获批临床。本次这款创新ADC在中国获批临床，意味着其将在中国进入临床研究阶段。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1258792.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4080","DSNKY","BK4231","BK4007","ADC"],"gpt_icon":0},{"id":"2516388637","title":"美国OTC市场第一三共盘中异动 股价大涨6.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516388637","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516388637?lang=zh_cn&edition=fundamental","pubTime":"2025-03-03 22:47","pubTimestamp":1741013229,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时47分，美国OTC市场第一三共股票出现波动，股价急速拉升6.75%。截至发稿，该股报24.50美元/股，成交量303股，换手率0.00%，振幅0.00%。美国OTC市场第一三共股票所在的制药行业中，整体涨幅为0.25%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303224709a25d44a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303224709a25d44a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DSNKY","BK4007"],"gpt_icon":0},{"id":"2514182100","title":"美国OTC市场第一三共盘中异动 早盘股价大涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514182100","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514182100?lang=zh_cn&edition=fundamental","pubTime":"2025-02-25 22:49","pubTimestamp":1740494941,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时49分，美国OTC市场第一三共股票出现波动，股价快速拉升5.08%。截至发稿，该股报23.81美元/股，成交量2.3324万股，换手率0.00%，振幅3.88%。美国OTC市场第一三共股票所在的制药行业中，整体涨幅为2.03%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225224901abdc82a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225224901abdc82a5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DSNKY","BK4007"],"gpt_icon":0},{"id":"2511293355","title":"美国OTC市场第一三共盘中异动 早盘快速拉升6.70%报24.53美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511293355","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511293355?lang=zh_cn&edition=fundamental","pubTime":"2025-02-13 22:46","pubTimestamp":1739457979,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日22时46分，美国OTC市场第一三共股票出现异动，股价大幅上涨6.70%。截至发稿，该股报24.53美元/股，成交量449股，换手率0.00%，振幅0.00%。最近的财报数据显示，该股实现营业收入31.82亿美元，净利润4.06亿美元，每股收益0.22美元，毛利23.39亿美元，市盈率29.86倍。美国OTC市场第一三共股票所在的制药行业中，整体涨幅为0.12%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213224619a244aeec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213224619a244aeec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","DSNKY"],"gpt_icon":0},{"id":"2510303289","title":"美国OTC市场第一三共盘中异动 早盘股价大跌6.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510303289","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510303289?lang=zh_cn&edition=fundamental","pubTime":"2025-02-12 22:47","pubTimestamp":1739371665,"startTime":"0","endTime":"0","summary":"北京时间2025年02月12日22时47分，美国OTC市场第一三共股票出现异动，股价急速下跌6.93%。截至发稿，该股报22.84美元/股，成交量3628股，换手率0.00%，振幅2.28%。美国OTC市场第一三共股票所在的制药行业中，整体涨幅为0.44%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212224745abcc6129&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212224745abcc6129&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DSNKY","BK4007"],"gpt_icon":0},{"id":"2508318512","title":"第一三共(DSNKY.US)与阿斯利康(AZN.US)潜在重磅抗癌ADC获推荐在欧盟上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2508318512","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508318512?lang=zh_cn&edition=fundamental","pubTime":"2025-02-02 15:21","pubTimestamp":1738480887,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，第一三共宣布，其与阿斯利康联合开发的抗体偶联药物datopotamab deruxtecan已获欧洲药品管理局人用药品委员会推荐上市，用于治疗不可切除或转移性激素受体阳性、HER2阴性乳腺癌的成年患者，这些患者需已接受过内分泌治疗，并曾接受过至少一线化疗治疗晚期疾病。DXd具有独特的作用机制，与常见化疗药物伊立替康相比，活性提高10倍。阿斯利康和第一三共在2020年7月达成协议，合作开发这款ADC。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1245199.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2417539215.USD","LU0889565916.HKD","LU1829250122.USD","ADC","BK4080","BK4585","BK4231","BK4588","DSNKY","LU2456880835.USD","LU0109394709.USD","LU2462157665.USD","BK4568","LU0320765992.SGD","AZN","LU2236285917.USD","BK4007"],"gpt_icon":0},{"id":"1186586220","title":"修正：第一三共公司第三季度每股收益同比增长至$0.22，销售额从$3.05B增长至$3.18B","url":"https://stock-news.laohu8.com/highlight/detail?id=1186586220","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186586220?lang=zh_cn&edition=fundamental","pubTime":"2025-01-31 22:06","pubTimestamp":1738332399,"startTime":"0","endTime":"0","summary":"第一三共公司公布季度每股收益为$0.22。这较去年同期每股收益$0.10增长了120%。本季度公司报告销售额为$31.8亿美元。以上内容来自Benzinga Earnings专栏，原文如下：Daiichi Sankyo Co  reported quarterly earnings of $0.22 per share. This is a 120 percent increase over earnings of $0.10 per share from the same period last year. The company reported $3.18 billion in sales this quarter. This is a 4.29 percent increase over sales of $3.05 billion the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DSNKY"],"gpt_icon":0},{"id":"1133176895","title":"第一三共公司第四季度每股收益0.22美元，同比增长0.10美元，销售额31.8亿美元，同比增长30.5亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1133176895","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133176895?lang=zh_cn&edition=fundamental","pubTime":"2025-01-31 15:40","pubTimestamp":1738309212,"startTime":"0","endTime":"0","summary":"第一三共公司报告季度每股收益为0.22美元。公司本季度销售额为31.8亿美元，比去年同期的30.5亿美元增长了4.29%。以上内容来自Benzinga Earnings专栏，原文如下：Daiichi Sankyo Co  reported quarterly earnings of $0.22 per share. This is a 120 percent increase over earnings of $0.10 per share from the same period last year. The company reported $3.18 billion in sales this quarter. This is a 4.29 percent increase over sales of $3.05 billion the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"第一三共公司第四季度每股收益0.22美元，同比增长0.10美元，销售额31.8亿美元，同比增长30.5亿美元","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DSNKY"],"gpt_icon":0},{"id":"2507464634","title":"美国OTC市场第一三共盘中异动 快速下跌5.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507464634","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507464634?lang=zh_cn&edition=fundamental","pubTime":"2025-01-29 22:46","pubTimestamp":1738161972,"startTime":"0","endTime":"0","summary":"北京时间2025年01月29日22时46分，美国OTC市场第一三共股票出现异动，股价快速下跌5.75%。截至发稿，该股报27.21美元/股，成交量2377股，换手率0.00%，振幅0.00%。美国OTC市场第一三共股票所在的制药行业中，整体跌幅为0.06%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250129224612abbc5e1b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250129224612abbc5e1b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","DSNKY"],"gpt_icon":0},{"id":"2505333272","title":"美国OTC市场第一三共盘中异动 早盘股价大涨9.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505333272","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505333272?lang=zh_cn&edition=fundamental","pubTime":"2025-01-21 22:46","pubTimestamp":1737470784,"startTime":"0","endTime":"0","summary":"北京时间2025年01月21日22时46分，美国OTC市场第一三共股票出现异动，股价快速上涨9.26%。截至发稿，该股报29.25美元/股，成交量985股，换手率0.00%，振幅0.95%。美国OTC市场第一三共股票所在的制药行业中，整体涨幅为1.82%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121224624a22a5a80&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121224624a22a5a80&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DSNKY","BK4007"],"gpt_icon":0},{"id":"2503299106","title":"第一三共(DSNKY.US)口服抗肿瘤新药在中国申报上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2503299106","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503299106?lang=zh_cn&edition=fundamental","pubTime":"2025-01-16 21:20","pubTimestamp":1737033637,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，1月15日，中国国家药监局药品审评中心官网最新公示，第一三共申报的5.1类新药盐酸吡昔替尼胶囊的上市申请已获得受理。公开资料显示，吡昔替尼是一款CSF1R小分子抑制剂，此前已于2019年8月获得美国FDA批准上市，治疗症状性腱鞘巨细胞瘤成人患者。根据FDA彼时的新闻稿介绍，这是其批准的首个治疗TGCT的治疗方法。目前手术是腱鞘巨细胞瘤的标准疗法。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1239016.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4007","DSNKY"],"gpt_icon":0},{"id":"2503578169","title":"阿斯利康(AZN.US)和第一三共(DSNKY.US)的抗体偶联药物datopotamab deruxtecan获FDA优先审评资格","url":"https://stock-news.laohu8.com/highlight/detail?id=2503578169","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503578169?lang=zh_cn&edition=fundamental","pubTime":"2025-01-14 21:20","pubTimestamp":1736860843,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，阿斯利康和第一三共今日宣布，为抗体偶联药物datopotamab deruxtecan提交的生物制品许可申请已被美国FDA接受，并授予优先审评资格，用于治疗经治局部晚期或转移性表皮生长因子受体突变非小细胞肺癌成年患者。FDA预计将在2025年第三季度完成审评。针对这一患者群体，datopotamab deruxtecan此前已被FDA授予突破性疗法认定。Datopotamab deruxtecan的安全性特征与此前在TROPION-Lung05和TROPION-Lung01试验中的报告一致，未发现新的安全性问题。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1237691.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2236285917.USD","LU2456880835.USD","AZN","LU0320765992.SGD","LU2417539215.USD","LU2462157665.USD","LU0109394709.USD","DSNKY","BK4007","BK4585","LU0889565916.HKD","LU1829250122.USD","BK4588","BK4568"],"gpt_icon":0},{"id":"2492045127","title":"第一三共(DSNKY.US)申报的DS-3939a临床试验申请已获得受理  为该产品首次在中国申报临床","url":"https://stock-news.laohu8.com/highlight/detail?id=2492045127","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492045127?lang=zh_cn&edition=fundamental","pubTime":"2024-12-19 20:50","pubTimestamp":1734612635,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，今日，中国国家药监局药品审评中心官网公示，第一三共申报的1类新药DS-3939a临床试验申请已获得受理。公开资料显示，DS-3939a是一种靶向TA-MUC1的抗体偶联药物，正在全球范围内处于1/2期临床研究阶段。根据CDE官网查询，本次为该产品首次在中国申报临床。体外研究表明，DS-3939a通过DXD介导的细胞毒作用表现出TA-MUC1依赖性的细胞生长抑制作用。此外，DS-3939a在几种TA-MUC1阳性癌细胞系来源的异种移植模型和各种PDX模型中表现出显著的抗肿瘤作用。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1227311.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1141","DSNKY","03347","BK1583","BK1576","BK4007"],"gpt_icon":0},{"id":"2479869787","title":"美国OTC市场第一三共盘中异动 早盘股价大涨5.46%报34.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479869787","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479869787?lang=zh_cn&edition=fundamental","pubTime":"2024-10-30 21:46","pubTimestamp":1730295970,"startTime":"0","endTime":"0","summary":"北京时间2024年10月30日21时46分，美国OTC市场第一三共股票出现异动，股价快速拉升5.46%。截至发稿，该股报34.02美元/股，成交量5.6476万股，换手率0.00%，振幅0.00%。美国OTC市场第一三共股票所在的制药行业中，整体跌幅为6.45%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103021461095bd8ea1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103021461095bd8ea1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DSNKY","BK4007"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":14}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DSNKY\",params:#limit:5,,,undefined,":[{"date":"2024-07-31","symbol":"DSNKY","type":"earning","reportTimeType":"","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1722412800000,"name":null,"time":"","dateTimestamp":1722398400000,"actualEps":null},{"market":"US","date":"2024-04-25","symbol":"DSNKY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1714017600000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2024-01-30","symbol":"DSNKY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1706590800000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2023-11-07","symbol":"DSNKY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1699333200000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2023-07-31","symbol":"DSNKY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1690776000000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DSNKY\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"DSNKY\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4118,"buy":0.5882,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5882,"analysts":17,"updateTime":1740801600000}}}